Table 3.

PRT rates in last 30 and 14 days of life by primary cancer diagnosis

Primary cancer diagnosis	Study cohort	Last 30 days				Last 14 days
		Decedents	% cohort	% PRT	# course	Decedents	% cohort	% PRT	# course
Lung	2,406	272	11.3	24.7	357	129	5.4	11.7	160
Breast	1,204	42	3.5	17.8	54	18	1.5	7.6	20
Colorectal	1,551	30	1.9	21.7	33	16	1.0	11.6	18
Prostate	1,438	43	3.0	19.7	53	20	1.4	9.2	24
Non-colorectal GI	1,454	59	4.1	24.0	69	23	1.6	9.3	24
Blood	938	34	3.6	23.3	50	9	1.0	6.2	17
Urinary	656	36	5.5	24.2	45	11	1.7	7.4	15
Female genital	623	15	2.4	14.3	15	5	0.8	4.8	5
Brain	255	8	3.1	17.8	9	*	*	8.9	*
Melanoma	265	13	4.9	23.2	16	*	*	7.1	*
Other	1,510	62	4.1	26.8	80	29	1.9	12.6	37
Overall	12,300	614	5.0	23.0	781	268	2.2	10.0	328

% cohort: Proportion of decedents received PRT in their last 30/14 days of life.

% PRT: Proportion of decedents who receive PRT courses in last year of life received PRT in their last 30/14 days of life.

#course: Number of PRT courses that decedents received in their last 30/14 days of life.

*Cell is suppressed due to small count.